TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $566 | -99.4% | 15 | -99.4% | 0.00% | – |
| Q2 2023 | $94,978 | +6099.6% | 2,504 | +3874.6% | 0.00% | – |
| Q1 2023 | $1,532 | -16.3% | 63 | 0.0% | 0.00% | – |
| Q4 2022 | $1,830 | -8.5% | 63 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 63 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 63 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -98.9% | 63 | -98.6% | 0.00% | – |
| Q3 2021 | $285,000 | +595.1% | 4,473 | +680.6% | 0.00% | – |
| Q2 2021 | $41,000 | -97.5% | 573 | -97.4% | 0.00% | -100.0% |
| Q1 2021 | $1,616,000 | +3.3% | 21,914 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $1,564,000 | -8.3% | 21,300 | -31.5% | 0.00% | 0.0% |
| Q3 2020 | $1,706,000 | -18.0% | 31,100 | -0.6% | 0.00% | -50.0% |
| Q2 2020 | $2,081,000 | +8.6% | 31,300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $1,916,000 | +6286.7% | 31,300 | +7844.2% | 0.00% | – |
| Q3 2019 | $30,000 | +900.0% | 394 | +1258.6% | 0.00% | – |
| Q2 2018 | $3,000 | +200.0% | 29 | +222.2% | 0.00% | – |
| Q1 2018 | $1,000 | -98.2% | 9 | -98.3% | 0.00% | – |
| Q4 2017 | $56,000 | -89.2% | 539 | -88.3% | 0.00% | – |
| Q3 2017 | $517,000 | -43.2% | 4,591 | -43.5% | 0.00% | -100.0% |
| Q2 2017 | $911,000 | -14.2% | 8,132 | -10.6% | 0.00% | 0.0% |
| Q1 2017 | $1,062,000 | +31.6% | 9,100 | +18.8% | 0.00% | 0.0% |
| Q4 2016 | $807,000 | +100.2% | 7,660 | +109.9% | 0.00% | – |
| Q3 2016 | $403,000 | +95.6% | 3,650 | +157.8% | 0.00% | – |
| Q2 2016 | $206,000 | -43.7% | 1,416 | -44.6% | 0.00% | – |
| Q1 2016 | $366,000 | -19.6% | 2,557 | -13.2% | 0.00% | – |
| Q4 2015 | $455,000 | -30.3% | 2,945 | -35.6% | 0.00% | -100.0% |
| Q3 2015 | $653,000 | +82.4% | 4,574 | +83.6% | 0.00% | – |
| Q2 2015 | $358,000 | +17800.0% | 2,491 | +16506.7% | 0.00% | – |
| Q1 2015 | $2,000 | -92.0% | 15 | -93.4% | 0.00% | – |
| Q1 2014 | $25,000 | – | 227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |